# Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)

> **NCT01406275** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 363 (actual)

## Conditions studied

- Otitis Maedia

## Interventions

- **DRUG:** Amoxicillin and clavulanate

## Key facts

- **NCT ID:** NCT01406275
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406275, "Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01406275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*